About Hutchison MediPharma

Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of around 300 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia and China.

Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly, Janssen and Nestlé Health Science in oncology and inflammation research & development.

HMP is a subsidiary of Chi-Med (Hutchison China MediTech).

website icon
Website
employees icon
Employees
industry icon
Industry
Pharmaceuticals
location icon
Location
Building 4, 917 Halei Road,,Shanghai,Shanghai,CN
description icon
Founded
2002
description icon
Keywords
Biotechnology, Pharmaceuticals, Research, Oncology, Ibd, China, Development, Pharma, Biotech, Shanghai, Cancer, Botanicals, Drugs, Inflammation, Lymphoma, Autoimmune Disease, Kinase Inhibitors, Targeted Therapies, Tumors, Nce

Hutchison MediPharma Alternatives

Industry
Pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals

Frequently Asked Questions about Hutchison MediPharma

Who is the CEO of Hutchison MediPharma?

Samantha Du is the CEO of Hutchison MediPharma. To contact Samantha Du email at [email protected].

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more